SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Novartis shares jump after positive data in experimental heart treatment

Novartis released results for two of three watched trials in the second half of the year. U.S.-listed shares soared 6% Tuesday to $161.25 on positive study data for an experimental treatment for…

NOT

By Catherine Dunn Novartis released results for two of the three trials that Wall Street had been watching for in the second half of the year. U.S.-listed Novartis shares rose 6% on Tuesday to $161.25 after positive study data on an experimental treatment for…

Related stories